Non-alcoholic fatty liver disease in pregnancy, paving the way for adverse pregnancy outcome risk assessment

Affiliations

Editorial

Ja-Young Kwon. Clin Mol Hepatol. 2022 Jan.

. 2022 Jan;28(1):50-51.

doi: 10.3350/cmh.2021.0359. Epub 2021 Nov 22.

¹ Department of Obstetrics and Gynecology, Institute of Women's Medical Life Science, Yonsei University College of Medicine, Seoul, Korea.

No abstract available

Keywords: Gestational diabetes; Non-alcoholic fatty liver disease; Preeclampsia; Pregnancy outcome.

Conflict of interest statement

Conflicts of Interest: The author has no conflicts to disclose.

Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis.
Leoni S, Tovoli F, Napoli L, Serio I, Ferri S, Bolondi L. Leoni S, et al. World J Gastroenterol. 2018 Aug 14;24(30):3361-3373. doi: 10.3748/wjg.v24.i30.3361. World J Gastroenterol. 2018. PMID: 30122876 Free PMC article.

1. Cunningham F, Leveno KJ, Bloom SL, Dashe JS, Hoffman BL, Casey BM, et al. Williams Obstetrics, 25e. New York: McGraw Hill; 2018. pp. 160–179.
1. Lain KY, Catalano PM. Metabolic changes in pregnancy. Clin Obstet Gynecol. 2007;50:938–948. - PubMed
1. El Jamaly H, Eslick GD, Weltman M. Systematic review with meta-analysis: non-alcoholic fatty liver disease and the association with pregnancy outcomes. Clin Mol Hepatol. 2022;28:52–66. - PMC - PubMed
1. Shang M, Lin L. IADPSG criteria for diagnosing gestational diabetes mellitus and predicting adverse pregnancy outcomes. J Perinatol. 2014;34:100–104. - PubMed
1. ACOG practice bulletin No. 190: gestational diabetes mellitus. Obstet Gynecol. 2018;131:e49–e64. - PubMed